Korea Union Pharmaceutical (080720) has 0 disclosed insider purchases and 0 disclosed disposals on record, filed by 0 distinct insiders. The earliest filing StockDrifts holds for Korea Union Pharmaceutical is dated 2024-08-14; the most recent is 2026-05-28.
| Date | Type | Source | Insider | Position | Shares | Price at filing | Return | Value |
|---|---|---|---|---|---|---|---|---|
| 2026-05-28 | BUY | 제3자배정유상증자 | 부광약품 Bukwang Pharmaceutical | - | 60.0M | ₩2,725 | +0.0% | ₩163.5B ($113.5M) |
| 2026-05-19 | BUY | 기타 | 박광석 Park Gwang-seok | - | 9.5M | ₩2,725 | +0.0% | ₩25.8B ($17.9M) |
| 2025-06-23 | BUY | 기타 | 멜빈에프앤비 Melvin F&B | - | 1.6M | ₩2,725 | +0.0% | ₩4.3B ($3.0M) |
| 2025-06-23 | SELL | 기타 | 백병하 Baek Byeong-ha | CEO | -720.6K | ₩2,725 | +0.0% | ₩2.0B ($1.4M) |
| 2025-06-23 | SELL | 기타 | 안희숙 Ahn Hee-sook | - | -856.0K | ₩2,725 | +0.0% | ₩2.3B ($1.6M) |
| 2024-12-09 | BUY | 장외매수 | 양태현 Taehyun Yang | Internal director | 3.1K | ₩2,725 | +0.0% | ₩9M ($6K) |
| 2024-11-06 | BUY | 증여취소 | 안희숙 Ahn Hee-sook | - | 285.2K | ₩2,725 | +0.0% | ₩777M ($540K) |
| 2024-11-06 | BUY | 증여취소 | 백병하 Baek Byeong-ha | CEO | 720.6K | ₩2,725 | +0.0% | ₩2.0B ($1.4M) |
| 2024-08-14 | SELL | 증여 | 백병하 Baek Byeong-ha | CEO | -720.6K | ₩6,060 | +55.0% | ₩4.4B ($3.0M) |
| 2024-08-14 | SELL | 증여 | 안희숙 Ahn Hee-sook | - | -285.2K | ₩6,060 | +55.0% | ₩1.7B ($1.2M) |
Every trade listed above comes from an official regulatory disclosure. For how StockDrifts scores these disclosures, see the Korea insider signal tier research, or browse every Korean stock we track.